Jump Financial’s Amylyx Pharmaceuticals AMLX Stock Holding History

Jump Financial’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$483K	Buy	+26,891	New	+$416K	﹤0.01%	1468
2025 Q3	–	Sell	-47,800	Closed	-$306K	–	1762
2025 Q2	$306K	Buy	+47,800	New	+$232K	﹤0.01%	1420
2025 Q1	–	Sell	-104,342	Closed	-$394K	–	1565
2024 Q4	$394K	Buy	+104,342	New	+$491K	0.01%	1192
2024 Q3	–	Sell	-17,685	Closed	-$33.6K	–	1615
2024 Q2	$33.6K	Buy	+17,685	New	+$34.3K	﹤0.01%	1698
2024 Q1	–	Sell	-13,343	Closed	-$196K	–	1871
2023 Q4	$196K	Sell	13,343 -9,497	-42%	-$146K	0.01%	1573
2023 Q3	$418K	Sell	22,840 -118,607	-84%	-$2.51M	0.02%	1109
2023 Q2	$3.05M	Buy	+141,447	New	+$3.82M	0.11%	246

Other funds holding AMLX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jump Financial's AMLX Position: Q2 2026 in Review

Jump Financial opened a new position in Amylyx Pharmaceuticals (AMLX) in Q2 2026: 26,891 shares worth $483K. The stake represents ﹤0.01% of the portfolio and ranks #1468 among its holdings. This is a return to the name: Jump Financial previously reported a position in AMLX as recently as Q2 2025.

Jump Financial first reported a position in AMLX in Q2 2023 and has held it in 7 quarters since. The position peaked at $3.05M in Q2 2023. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

Jump Financial held 26,891 shares of Amylyx Pharmaceuticals worth $483K as of Q2 2026.
Amylyx Pharmaceuticals was a new Jump Financial position in Q2 2026.
Amylyx Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1468 holding.
Jump Financial first reported a position in Amylyx Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
Jump Financial's Amylyx Pharmaceuticals position peaked at $3.05M in Q2 2023.
206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.